mr4b
Tuesday, March 29, 2016
Deal Professor: Explaining Valeant: The Main Theories
Reasons given for the turmoil at Valeant Pharmaceuticals include its cuts in research and development, its drug pricing and investors' influence.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment